Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

RSV Diagnostics Companies

Respiratory Syncytial Virus (RSV) diagnostics companies focus on developing tests and technologies to detect and diagnose infections caused by the RSV, a common respiratory virus. RSV is a major cause of respiratory tract infections, especially in infants and older adults. 

RSV Diagnostics Key Companies

 

Latest RSV Diagnostics Companies Update


BD (Becton, Dickinson and Company) receives Emergency Use Authorization (EUA) from the FDA for its BD MAX Molecular Diagnostic System combo test simultaneously detects SARS-CoV-2, influenza A+B, and RSV, offering healthcare professionals a rapid and comprehensive diagnostic tool.


Cepheid launches Xpert® Xpress RSV/Flu/Adenovirus multiplex real-time PCR test rapidly identifies RSV, influenza A and B, and adenovirus from nasopharyngeal swab specimens.


Abbott introduces ID NOWâ„¢ COVID-19/RSV/Flu Combo Test rapid molecular test delivers results in about 15 minutes, enabling quick and accurate diagnosis at the point of care.


Roche Diagnostics partners with QIAGEN to develop and commercialize a combined RSV and influenza A/B test collaboration leverages both companies' expertise in molecular diagnostics to offer a comprehensive solution for respiratory virus detection.


LumiraDX enters into a strategic partnership with GSK plc to expand access to its rapid RSV test in developing countries initiative aims to improve RSV diagnosis and management in regions with limited resources.


List of RSV Diagnostics Key Companies in the Market



  • Quest Diagnostics

  • Biomerieux

  • Becton

  • Dickinson

  • and Company (BD)

  • Abbott

  • Hoffman-La Roche Ltd.

  • Danaher Corporation

  • Thermo Fisher Scientific

  • Biocartis

  • Luminex

  • Hologic

  • Fast Track Diagnostics

  • Bio-Rad Laboratories Inc.

  • Alere Inc.

  • Quidel Corporation


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.